Pisit Hutayanon

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.7K citations · Full text

Diabetes Management, Cardiovascular Disease, Diabetes +6

New strategy of α- and γ-tocopherol to prevent contrast-induced acute kidney injury in chronic kidney disease patients undergoing elective coronary procedures

Adis Tasanarong, Anchalee Vohakiat, Pisit Hutayanon et al. · Nephrology Dialysis Transplantation · 2013 · 61 citations · Full text

Management and 1‐Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD‐AF Registry

Shinya Goto, Pantep Angchaisuksiri, Jean‐Pierre Bassand et al. · Journal of the American Heart Association · 2019 · 54 citations · Full text

Urinary Neutrophil Gelatinase-Associated Lipocalin predicts the severity of contrast-induced acute kidney injury in chronic kidney disease patients undergoing elective coronary procedures

Adis Tasanarong, Pisit Hutayanon, Dilok Piyayotai · BMC Nephrology · 2013 · 47 citations · Full text

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry

Jitendra PS. Sawhney, V A Kothiwale, Vikas Bisne et al. · Indian Heart Journal · 2018 · 21 citations · Full text